- Market Capitalization, $K 160,174
- Shares Outstanding, K 23,800
- Annual Sales, $ 10,510 K
- Annual Income, $ -56,020 K
- 60-Month Beta 0.88
- Price/Sales 14.50
- Price/Cash Flow N/A
- Price/Book 1.14
|Period||Period Low||Period High||Performance|
| || |
+1.06 (+18.03%)since 10/11/19
| || |
-3.32 (-32.36%)since 08/09/19
| || |
-9.12 (-56.79%)since 11/09/18
SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on September 27th, 2019 at $7.93. In approximately 1 month, Concert Pharmace has returned 15.84% as of today's recent price of $6.67....
Concert (CNCE) delivered earnings and revenue surprises of 15.29% and -97.14%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $17.2 million in its third quarter.
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2019.
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will host a conference call and webcast event with a key opinion leader in the field of psychiatry and schizophrenia on Thursday, November...
Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2019 financial results on Thursday, November 7, 2019, before the U.S. financial markets open. The Company...
SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on September 27th, 2019 at $7.93. In approximately 3 weeks, Concert Pharmace has returned 21.64% as of today's recent price of $6.21....
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented results from its recently completed Phase 2 dose-ranging trial of the investigational medicine CTP-543 in patients with moderate-to-severe alopecia...
--Webcast details for Cantor Healthcare Conference presentation Thursday, October 3, 2019 at 5:20 p.m. ET
|U.S. Liquidity Factor Vanguard ETF|
|Micro-Cap Ishares ETF|
|Nasdaq Biotechnology Ishares ETF|
|Russell 2000 Value Vanguard|
|US Innovative Healthcare Ishares Evolved ETF|